{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T13:21:23Z","timestamp":1721827283045},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,1,20]]},"DOI":"10.7759\/cureus.12808","type":"journal-article","created":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T15:47:55Z","timestamp":1611157675000},"source":"Crossref","is-referenced-by-count":0,"title":["Impact of Angiotensin-Converting Enzyme Inhibitors\/Angiotensin Receptor Blockers on Renal Function in Chronic Kidney Disease Patients Undergoing Coronary Angiography"],"prefix":"10.7759","author":[{"given":"Arunee T","family":"Motes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Praveen","family":"Ratanasrimetha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sariya","family":"Wongsaengsak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuttiwat","family":"Vorakunthada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thammasak","family":"Mingbunjerdsuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camillo","family":"Pena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth","family":"Nugent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Prevention of contrast-induced acute kidney injury associated with angiography. (2020). Accessed. March 23, 2020: https:\/\/www.uptodate.com\/contents\/prevention-of-contrast-induced-acute-kidney-injury-associated-with-angiography?topi...."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-199615030-00005","article-title":"ACE inhibitors and the kidney. A risk-benefit assessment","volume":"15","author":"Navis G","year":"1996","unstructured":"Navis G, Faber HJ, de Zeeuw D, de Jong PE. ACE inhibitors and the kidney. A risk-benefit assessment. Drug Saf. 1996, 15:200-211. 10.2165\/00002018-199615030-00005","journal-title":"Drug Saf"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(83)90618-6","article-title":"Hospital-acquired renal insufficiency: a prospective study","volume":"74","author":"Hou SH","year":"1983","unstructured":"Hou SH, Bushinsky DA, Wish JB, Cohen JJ, Harrington JT. Hospital-acquired renal insufficiency: a prospective study. Am J Med. 1983, 74:243-8. 10.1016\/0002-9343(83)90618-6","journal-title":"Am J Med"},{"key":"ref4","article-title":"Contrast-induced nephropathy among Israeli hospitalized patients: incidence, risk factors, length of stay and mortality","volume":"11","author":"Shema L","year":"2009","unstructured":"Shema L, Ore L, Geron R, Kristal B. Contrast-induced nephropathy among Israeli hospitalized patients: incidence, risk factors, length of stay and mortality. Isr Med Assoc J. 2009, 11:460-4.","journal-title":"Isr Med Assoc J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2004.06.068","article-title":"A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation","volume":"44","author":"Merhan R","year":"2004","unstructured":"Merhan R, Aymong ED, Nikolsky E, et al.. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 2004, 44:1393-9. 10.1016\/j.jacc.2004.06.068","journal-title":"J Am Coll Cardiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.110.953851","article-title":"Contrast-induced acute kidney injury","volume":"122","author":"Solomon R","year":"2010","unstructured":"Solomon R, Dauerman HL. Contrast-induced acute kidney injury. Circulation. 2010, 122:2451-5. 10.1161\/CIRCULATIONAHA.110.953851","journal-title":"Circulation"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(97)00150-2","article-title":"Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality","volume":"103","author":"McCullough PA","year":"1997","unstructured":"McCullough PA, Wolyn R, Rocher LL, Levin RN, O\u2019Neill WW. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med. 1997, 103:368-75. 10.1016\/S0002-9343(97)00150-2","journal-title":"Am J Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2006.01.019","article-title":"Epidemiology and prognostic implications of contrast-induced nephropathy","volume":"98","author":"McCullough PA","year":"2006","unstructured":"McCullough PA, Adam A, Becker CR, et al.. Epidemiology and prognostic implications of contrast-induced nephropathy. Am J Cardiol. 2006, 98:5-13. 10.1016\/j.amjcard.2006.01.019","journal-title":"Am J Cardiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2147\/DHPS.S122207","article-title":"Update on the renal toxicity of iodinated contrast drugs used in clinical medicine","volume":"9","author":"Andreucci M","year":"2017","unstructured":"Andreucci M, Faga T, Serra R, De Sarro G, Michael A. Update on the renal toxicity of iodinated contrast drugs used in clinical medicine. Drug Healthc Patient Saf. 2017, 9:25-37. 10.2147\/DHPS.S122207","journal-title":"Drug Healthc Patient Saf"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1159\/000339789","article-title":"KDIGO clinical practice guideline for acute kidney injury","volume":"120","author":"Khwaja A","year":"2012","unstructured":"Khwaja A. KDIGO clinical practice guideline for acute kidney injury. Nephron Clin Pract. 2012, 120:c179-84. 10.1159\/000339789","journal-title":"Nephron Clin Pract"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-012674","article-title":"What are the risks and benefits of temporarily discontinuing medications to prevent acute kidney injury? A systematic review and meta-analysis","volume":"7","author":"Whiting P","year":"2017","unstructured":"Whiting P, Morden A, Tomlinson LA, et al.. What are the risks and benefits of temporarily discontinuing medications to prevent acute kidney injury? A systematic review and meta-analysis. BMJ Open. 2017, 7:e012674. 10.1136\/bmjopen-2016-012674","journal-title":"BMJ Open"},{"key":"ref12","article-title":"Renal safety and angiotensin II blockade medications in patients undergoing non-emergent coronary angiography: a randomized controlled study","volume":"15","author":"Wolak T","year":"2013","unstructured":"Wolak T, Aliev E, Rogachev B, Baumfeld Y, Cafri C, Abu-Shakra M, Novack V. Renal safety and angiotensin II blockade medications in patients undergoing non-emergent coronary angiography: a randomized controlled study. Isr Med Assoc J. 2013, 15:682-7.","journal-title":"Isr Med Assoc J"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-008-9368-1","article-title":"The effect of withdrawal of ACE inhibitors or angiotensin receptor blockers prior to coronary angiography on the incidence of contrast-induced nephropathy","volume":"40","author":"Rosenstock JL","year":"2008","unstructured":"Rosenstock JL, Bruno R, Kim JK, et al.. The effect of withdrawal of ACE inhibitors or angiotensin receptor blockers prior to coronary angiography on the incidence of contrast-induced nephropathy. Int Urol Nephrol. 2008, 40:749-55. 10.1007\/s11255-008-9368-1","journal-title":"Int Urol Nephrol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2015.04.019","article-title":"Effects of withdrawing vs continuing renin-angiotensin blockers on incidence of acute kidney injury in patients with renal insufficiency undergoing cardiac catheterization: Results from the Angiotensin Converting Enzyme Inhibitor\/Angiotensin Receptor Blocker and Contrast Induced Nephropathy in Patients Receiving Cardiac Catheterization (CAPTAIN) trial","volume":"170","author":"Bainey KR","year":"2015","unstructured":"Bainey KR, Rahim S, Etherington K, et al.. Effects of withdrawing vs continuing renin-angiotensin blockers on incidence of acute kidney injury in patients with renal insufficiency undergoing cardiac catheterization: Results from the Angiotensin Converting Enzyme Inhibitor\/Angiotensin Receptor Blocker and Contrast Induced Nephropathy in Patients Receiving Cardiac Catheterization (CAPTAIN) trial. Am Heart J. 2015, 170:110-6. 10.1016\/j.ahj.2015.04.019","journal-title":"Am Heart J"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1908879","article-title":"Contrast associated acute kidney injury","volume":"381","author":"Mohandas R","year":"2019","unstructured":"Mohandas R, Dass B, Ejaz AA. Contrast associated acute kidney injury. New Engl J Med. 2019, 381:1295. 10.1056\/NEJMc1908879","journal-title":"New Engl J Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/49764-impact-of-angiotensin-converting-enzyme-inhibitorsangiotensin-receptor-blockers-on-renal-function-in-chronic-kidney-disease-patients-undergoing-coronary-angiography","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:33:01Z","timestamp":1707507181000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/49764-impact-of-angiotensin-converting-enzyme-inhibitorsangiotensin-receptor-blockers-on-renal-function-in-chronic-kidney-disease-patients-undergoing-coronary-angiography"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,20]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.12808","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1,20]]}}}